"Randomized phase II study of azacitidine +/- lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
Year of publication
2022
Authors
Rasmussen, Bengt; Gohring, Gudrun; Bernard, Elsa; Nilsson, Lars; Tobiasson, Magnus; Jadersten, Martin; Garelius, Hege; Dybedal, Ingunn; Gronbaek, Kirsten; Ejerblad, Elisabeth; Lorenz, Fryderyk; Flogegard, Max; Marcher, Claus Werenberg; oster Fernstrom, Annette; Cavelier, Lucia; Papaemmanuil, Elli; Ebeling, Freja; Kittang, Astrid Olsnes; Norgaard, Jan Maxwell; Saft, Leonie
Show moreOrganizations and authors
University of Helsinki
Ebeling Freja
Helsinki University Hospital
Ebeling Freja
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Other article
Audience
ScientificPeer-reviewed
Non Peer-ReviewedMINEDU's publication type classification code
B1 Non-refereed journal articlesPublication channel information
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Partially open publication channel
License of the publisher’s version
CC BY
Self-archived
Yes
License of the self-archived publication
CC BY
Other information
Fields of science
Cancers
Publication country
United Kingdom
Internationality of the publisher
International
Language
English
International co-publication
Yes
Co-publication with a company
No
DOI
10.1038/s41375-022-01537-w
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes